Go to deals
Private Equity | Agriculture | Consumer & Retail

Zamira Australia has raised US$5.4 million to fund Companion Animal’s growth initiatives

Zamira Australia has completed a fundraising to support Companion Animal’s growth initiatives and further strengthen its balance sheet.

Zamira is an Australian animal health brand whose mission is to improve the health and well-being of animals across the world. The company is favorably positioned as a premium brand, with localized understanding and expertise – a trusted and strong Australian brand identity amongst its international competitors. The Companion Animal range is Zamira’s new line of Australian-made premium supplements for pets. Formulated by Australian vets using ethically sourced ingredients, ZamiPet helps support digestive and immune function, maintain vitality, joint health, cognitive function, skin, coat and nails, as well as helping support the reduction of stress, tension and anxiety in dogs.

Oaklins’ team in Australia acted as corporate advisor and lead manager to the raise and continues to support Zamira as they strive to become a leader in pet health and well-being, and a global leader in the supply of animal health products.

Service
Funding, debt advisory & ECM
Parties

Talk to the deal team

 Justin  Lewis

Justin Lewis

Managing Director

Melbourne, Australia
Oaklins Henslow

Related deals

Matera has acquired a majority stake in Onidata Tecnologia
Private Equity | Financial Services | TMT

Matera has acquired a majority stake in Onidata Tecnologia

Matera has acquired a majority stake in Onidata Tecnologia.

Learn more
Frediani has been acquired by The Florence Group
Private Equity | Consumer & Retail

Frediani has been acquired by The Florence Group

The Frediani family have sold Frediani S.r.l. to The Florence Group.

Learn more
Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes
Private Equity | Healthcare

Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes

Groupe Serenis and three other independent clinics have acquired Clinique du Chateau de Vernhes from the funding family.

Learn more